T cell responses to HIV Gag have been correlated with viral control; hence, the inclusion of Gag in HIV vaccine candidates where it could impact on early control via CD8+ T-cells at the site of infection, control spread from the entry portal, and control viraemia if infection is established [20]. This evidence concerns the gene CD8A and infection.